Curriculum vitae Alexis Edwin Te, M.D. Date of Preparation: April 28, 2010

Transcription

Curriculum vitae
Alexis Edwin Te, M.D.
Date of Preparation: April 28, 2010
A.
BACKGROUND INFORMATION
Office Address:
B.
Brady Prostate Center
Department of Urology
Weill Cornell Medical College of Cornell University
New York Presbyterian Medical Center
525 East 68th Street, Suite F9 West, Box 261
New York, New York 10021
(212) 746-4811 Office
(212) 746-5329 Office Fax
EDUCATIONAL BACKGROUND
High School:
1976-1980
Awarded: 1980
Polytechnic Preparatory Country Day School
Brooklyn, NY
High School Diploma
Cum Laude Honor Society
College:
1980-1984
Awarded: 1984
Yale University
New Haven, CT
BS- Molecular Molecular Biophysics & Biochemistry
Associate Member of Sigma Xi Research Society
Medical School
1984-1988
Awarded: 1988
Cornell University Medical College
New York, NY
Medical Doctorate
C.
PROFESSIONAL POSITIONS AND EMPLOYMENT
Postgraduate Training
Intern:
1988-1989
Department of Surgery
Columbia Presbyterian Medical Center
New York, NY
Resident:
1989-1990
Department of Surgery
New York, NY
Resident:
1990-1994
J. Bentley Squire Urologic Clinic
New York, NY
Chief Resident:
1994
J. Bentley Squire Urologic Clinic
New York, NY
Fellowship:
1995
Neurourology and Urodynamics
College of Physician and Surgeons, Columbia University
New York, NY
Academic Positions:
1994-1995
Fellow in Neurourology and Urodynamics
College of Physicians & Surgeons, Columbia University
1995-2000
Assistant Professor of Urology
College of Physicians and Surgeons, Columbia University
2000-2001
Assistant Clinical Professor of Urology
2001-2009
Adjunct Assistant Professor of Urology
2000-2002
Assistant Professor of Urology
Weill Medical College of Cornell University
2002-2009
Associate Professor of Urology
2002-2010
Professor of Urology
Hospital Positions:
1994-1995
Clinical Assistant in Urology
J. Bentley Squier Urologic Clinic
1994-2000
Attending in Surgery
Helen Hayes Hospital
West Havestraw, NY
1995-2000
1995-1996
Junior Assistant Attending in Urology
Director of Neurourology & Urodynamics
St. Luke’s-Roosevelt Hospital Center
1995-2009
1995-2000
Assistant Attending in Urology
Co-Director of Incontinence Care Center
J. Bentley Squier Urologic Clinic
1996-2004
1996-2006
2006-2010
Director of the Incontinence Care Center
Assistant in Surgery
Courtesy Staff
Neurourology and Urodynamics Laboratory
Division of Urology
Maimonides Medical Center
2002-Present
Consultant-NYPH
Hospital for Special Surgery
2000-Present
Director of the Brady Prostate Center and Urodynamics
Attending in Urology
New York Presbyterian Medical Center/ Weill Cornell
Center
Other employment: N/A
D.
Licensure, Board Certification and Malpractice:
1.
Licensure
a. State
New York State
Date of Issue Date of last renewal
1989
2008
c. DEA Certification
2.
Current
Board Certification
Full Name of Board: American Board of Urology
Certificate # 11868
Date of 1st Issue: February 28, 1998
Date of Issue: February 28, 2008
Date of Next Recertification: February 28, 2018
3.
Malpractice Insurance
Do you have Malpractice Insurance? Yes
Name of Provider: MCIC
Premiums paid by WCMC
E.
Memberships in Associations:
Title
Member
Member
Member
Member
Member
Member
Member
Member
Member
Member
Member
Fellow
F.
Organization
American Urological Association
American Urologic Association/New York Section
American Medical Association
Philippino Chinese Medical Association
Medical Society of the State of New York
Chinese American Medical Assocation
Endourologic Society
Society of Urodynamics and Female Urology
American Academy of Science
Society of International Urology/ Societe Urologie International
National Association For Continence
The New York Academy of Medicine
Date Joined
1994
1994
1994
1995
1994
2002
1998
1998
2000
2006
2005
2008
Honors and Awards:
Sigma Xi Research Society, Associate Member, 1984
Outstanding Achievements in Medicine, Philippine Chinese Medical Association, 1995
Outstanding Young Man, Philippine Chinese Association of America, 1996
New York Harvest Award, UST Medical Alumni Association, 1997
Rising Star Award, Poly Preparatory Country Day School Board of Alumni, 1999
Medicine Achievement Award, Philippine Chinese Association, 2002
Distinguished Physician Award, Philippine Chinese Medical Association 2004
SUFU Best Video Award- 1St Prize 2008
AUA Best Video Award-1st Prize 2008
SuperDocs 2008, 2009, 2010
Castle Connelly: Best Doctor in NY Metro Area: Urology 2007, 2008. 2009, 2010
Consumer's Research Council of America: Top Physicians 2004-2009
Best Doctors in America Datatbase: 2009, 2010
Marquis Who’s Who in America 2009
Cornell Patents
1.
Patent Application Submitted April 9, 2009 to US Patent Office. Assigned to
Cornell University. Te AE, Rey D, Batts C. NANOPARTICLE-MEDIATED
MICROWAVE
THERMOTHERAPY AND TISSUE TREATMENT METHODS
BASED THEREON
G.
HOSPITAL/INSTITUTINAL AFFILIATION
1.
2.
Primary Hospital Affiliation: New York Presbyterian Hospital (Cornell)
Other Hospital Affiliation: Hospital for Special Surgery
H.
EMPLOYMENT STATUS
1.
2.
Name of Current Employer(s): Weill Cornell Medical College
Employment Status: Full-time salaried by Cornell
I.
CURRENT AND PAST INSTITUTIONAL RESPONSIBILITIES AND PERCENT
EFFORT
1.
Teaching (e.g., specific teaching functions, courses taught, dates)
Resident Education (Grands Rounds, Mortality and Morbidity): 1990- Present
Fellowship Education (Co-Mentor and Fellowship Supervisor): 1995-Present
Cornell Fellows Trained:
Jaspreet Sandhu, MD
2004-2005
William Jaffe, MD
2004-2005
Balaji Reddy, MD
2004-2006
Ricardo Gonzalez, MD
2005-2006
-NY Academy of Medicine Valentine Fellow
Rajiv Saini, MD
2006-2007
Eddie Zoltan, MD
2007-2008
Doreen Chung, MD
2008-Present
Richard Lee, MD
2009- Present
BioMedical Graduate Education (Summer Mentor):2005-Present
Weill-Ithaca Cornell Biomedical Summer Immersion Program
Clerkship Sponsor
Cameron Bardliving
2008
Diego Rey
2.
2005
Clinical care
Focus on voiding dysfunction in adults and diseases of the prostate and bladder including
neurourology and urodynamics, female urology, incontinence, benign prostatic
hyperplasia, prostatitis, prostate cancer, chronic pelvic pain syndromes, and lower urinary
tract pathology: 1995-Present
3.
Administrative duties
Institutional Responsibilities:
Founding Webmaster of http://urology.columbia.edu
Department of Urology, Columbia University Website
1995-2000
Public Relations Committee
Department of Urology, Columbia University
1995-2000
Computer Committee
Department of Urology, Columbia University
1995-2000
Director of Neurourology & Urodynamics
Department of Urology, St. Luke’s-Roosevelt Hospital Center
1995-1996
Co-Director of Incontinence Care Center
1995-2000
J. Bentley Squier Urologic Clinic, Columbia Presbyterian Medical Center
Director of the Incontinence Care Center
Division of Urology, Maimonides Medical Center
1996-2004
Compliance Leader
Department of Urology, Cornell University
2002
Formulary and Therapeutics Committee
New York Presbyterian Medical Center
2003-Present
Institutional Review Board Member
2008-Present
Director of the Brady Prostate Center and Urodynamics
2000-Present
Department of Urology, New York Presbyterian, Weill Cornell Medical College
4.
Research
Current Research Experience:
Cornell University, Department of Urology
1995- Present
Weill Cornell Medical College
New York,NY
Associate Professor of Urology
Areas of Current Research: Benign Prostatic Hyperplasia (BPH), Therapies in BPH,
Incontinence, Prostatitis, Neurourology and Urodynamics, Female Urology, Interstitial
Cystitic, Laser Surgery, Prostate Cancer
Past Research Experience
Columbia University
College of Physicians and Surgeons
Sponsors: Steven A. Kaplan, M.D. & Carl A. Olsson, M.D.
Topic: Transurethral Electrovaporation of the Prostate
1994-1995
New York,NY
Columbia University
1992-1994
College of Physicians and Surgeons
New York,NY
Sponsors: Steven A. Kaplan,M.D., Ridwan Shabsigh,M.D.,Ralph Buttyan,Ph.D.& Carl
Olsson, M.D.
Topic: Neurotrophic factors in developing and diabetic bladders and penis
Castration-Induced Apoptosis in the Rat Penis
Cornell University Medical College
July 1987
Brady Urology Research Laboratory
New York,NY
Sponsor: E. Darracott Vaughan,Jr.,M.D.
Topic: Intraperitoneal infusion of alkaline irrigating solutions used in uric acid stone
treatment
University of California, San Francisco
Summer 1985
Department of Biophysics & Biochemistry
San Francisco,CA
Sponsor: Robert Fletterick, Ph.D.
Topic: Isolation of human liver glycogen phosphorylase gene from human genomic
cDNA library
Yale University
Academic Year 1983-1984
Department of Molecular Biophysics & Biochemistry
New Haven, CT
Sponsor: W. Dean Rupp, Ph.D.
Topic: The DNA sequence of the uvrB gene in E. Coli.
University of California, San Francisco
Summer 1983
Department of Biophysics & Biochemistry
San Francisco, CA
Sponsor: Robert Fletterick, Ph.D.
Topic: The DNA sequence of human muscle glycogen phosphorylase
Yale University Medical School
Academic year 1982-83
Department of Cardiovascularpathophysiology
New Haven, CT
Sponsor: S. Evans Downing, M.D.
Topic: Biochemical assay to measure heart muscle scars in rabbits
The New York Blood Center
Department of Cell Biochemistry
Sponsor: Jack Goldstein, Ph.D.
Topic: Protein purification of N- Acetyl-D-Galactosaminodase
Summer 1982
New York,NY
The Jackson Laboratory
Sponsor: David E. Harrison, Ph.D.
Topic:Water solubility changes of collagen in aging mice skin
Summer 1979
Bar Harbor, Maine
Current Percent Effort (%)
Teaching
10%
Clinical Care
50%
Administration
5%
Research
35%
J.
Does the activity involve WMC students/researchers? (Yes/No)
Yes
No
No
Yes
RESEARCH SUPPORT
Principle Investigator
1.
2.
2.
3.
Clinical efficacy and tolerability/safety of tolterodine prolonged release capsules.
A open labeled multinational extended study in patients with symptoms of
overactive bladder
Funding Source: Pharmacia UpJohn
Duration: 2000-2001
A randomized, double-blind, placebo controlled, fixed dose study to evaluate the
safety and efficacy of LU 25-109 in the treatment of adult patients with overactive
bladder.
Funding Source: Forest Laboratories
Duration: 1999-2000
The long-term efficacy and safety of alfuzosin 10mg OD (once a day) on the risk
of acute urinary retention and the need for surgery in patients with BPH (benign
prostatic hyperplasia). A two-year, randomized, multicenter, double-blind,
parallel group, placebo-controlled study.
Funding Source: Sanofi-Synthelabo
Duration: 2001-2005
A double-blind randomized parallel group study of alfuzosin 10mg OD (once a
day) versus placebo in the management of acute urinary retention in patients with
a first episode due to BPH (Benign Prostatic Hyperplasia)
Funding Source: Sanofi-Synthelabo
Duration: 2001-2003
4.
5.
6.
7.
8.
9.
10.
11.
12.
14.
A Multi Center Study of the Tolerability, Efficacy, and Safety of Transperineal
Prostatic Block or Transrectal Ultrasound Block as Primary Methods of Local
Anesthesia for Interstitial Laser Thermal Therapy In An Outpatient Clinic Setting
In Subjects with Symptomatic Benign Prostatic Hyperplasia
Funding Source: Ethicon Endosurgery
Duration: 2001-2002
A Double-Blind Placebo-Controlled, Pilot Study to Teat Patients with Moderate
to Severe Progressive Benign Prostatic Hypertrophy with Phenoxybenzamine
(Dibenzyline).
Funding Source: Wellspring Pharmaceuticals Inc.
Duration: 2001-2003
A Postmarket data collection study of the uroflometry effects and symptom
alleviations of the Thermoflex™ System in patients suffering form benign
prostatic hyperplasia (BPH)
Funding Source: Argomed, Inc.
Duration: 2000-2002
Prostate Specific Antigen ( PSA) Density of the Transition Zone in Ethnically
Diverse Men DAMD17-99-1-9041
P.I. % effort: 25
Funding Source: Department of Defense
Duration: 1999
The Use of a Bipolar Electrovaporization Technique utilizing the Gyrus
PlasmaKinetic Electrosurgical System with Isotonic Saline Irrigating Solution in
the Treatment of Benign Prostatic Hyperplasia
Funding Source: Gyrus
Duration: 2000-2001
Clinical efficacy and tolerability/safety of tolterodine prolonged release capsules
and tolterodine immediate release tablets vs placebo. A randomized, doubleblind, placebo-controlled, multinational study in patients with symptoms of
overactive bladder
Funding Source: Pharmacia UpJohn
Duration: 1999-2000
A Multi-Center Clinical Evaluation of the 80W KTP Laser Prostatectomy for the
Treatment of Benign Prostatic Hyperplasia
Funding Source: Laserscope, Inc.
Duration:2002-2003
Evaluation of RDP58 in a mouse model of acute and chronic interstitial cystitis
Funding Source: Sangstat, Inc.
Duration: 2002-2003
A Phase I/II Dose Escalation Study to Asses the Safety, Tolerability, and
Preliminary Efficacy of Transurethral Photodynamic Therapy with QLT0074 for
Benign Prostatic Hyperplasia
Funding Source: QLT, Inc
Duration: 2003-2004
A Randomized, Double- Blind, Placebo-Controlled, Parallel Group Study of the
Efficacy and Safety of Dutasteride 0.5mg Administered Orally Once Daily for
Four Years to Reduce the Risk of Biopsy- Detectable Prostate Cancer
15
16
17
18.
19.
20.
21.
22.
Funding Source: Glaxo Smith Kline
Duration: 2003-2005
Protocol H6D-MC-LVHK: A Randomized, Double-Blind, Placebo-Controlled,
Parallel-Design, Multicenter Study to Evaluate the Urodynamic Effects of
Tadalafil Once a Day for 12 weeks in Men with Signs and Symptoms of BPH
Funding Source: Lilly Icos
Duration:2006-2008
A Phase 2, Randomized, Double-Blind, Parallel Group, Placebo Controlled,
Multi-Center Study to Evaluate the Urodynamic and Safety of YM178 in Male
Subjects with Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet
Obstruction (BOO)-I-3
Funding Source: Astellas
Duration: 2006-2007
A Pilot Study to Measure the Efficacy of Long-Acting Tolterodine on Continued
Detrussor Overactivity in Patients that Have Undergone Treatment for Bladder
Outlet Obstruction
Funding Source: Pfizer
Duration: 2007-Present
Randomized Double-Blind Placebo Controlled Trial of Intradetrusor Injections of
Botox for the Treatment of Urinary Incontinence Secondary to Benign Prostatic
Hyperplasia BTX0621
Funding Source: Allergan
Duration: 2007-Present
Examination of High Power (120W) Laser Energy in Canine Prostatectomy
Funding Source: AMS
Duration: 2006
A Prospective Evaluation of the Greenlight Model 120 Laser System for the
Treatment of Benign Prostatic Hyperplasia
Funding Source: Laserscope
Duration: 2006-2007
Sanofi-Synthelabo Prospective, Observational Registry and Patient Survey of the
Management of Men with Benign Prostatic Hyperplasia (BPH): BPH Registry
and Patient Survey
Funding Source: Sanofi-Aventis
Duration: 2005-2007
A Randomized, Double-Blind, Placebo-Controlled, Dose Comparison Study of
the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign
Prostatic Hyperplasia
Funding Source: Threshold
Duration: 2005-2006
Co- Investigator
1.
Microwave Thermotherapy vs. TURP, a randomized comparative study
PI: Steven A. Kaplan
2.
3.
4.
5.
6.
7.
K.
Funding Source: Urologix, Inc., Minneapolis, MN.
Duration: 1996-1999
Peripheral Sacral Nerve Stimulation for the treatment of Voiding Dysfunctions
Funding Source: Medtronics, Inc., Minneapolis, MN.
Duration: 1997-2000
Medical Therapy of BPH Study (MTOPS): A 6 year study
UO1 DK46418 – 04
Co-PI % effort: 20
Funding Source: NIH
Duration: 1995-2000
Electrovaporization of the prostate in men with benign prostatic hyperplasia
Funding Source: Circon ACMI
Duration: 1994-1996
Vaporization versus TURP in the management of BPH
Funding Source: Circon ACMI
Duration: 1995-1996
Urodynamic and Multiethnic Variability of Men Treated by Minimally Invasive
Surgical Therapies
DK4641
Co-PI % effort: 10
Funding source: NIH
Duration: 2002-2009
Complementary and Alternative Medical Therapy to Urology Symptoms
DK
Co-PI% effort: 10
Funding Source:NIH
Duration: 2004-2011
EXTRAMURAL PROFESSIONAL RESPONSIBILITIES
Editorial Responsibilities:
Assistant Editor, Journal of Urology
2007-Present
Web Alerts Editor, Current Urology Reports
2000-Present
Literature Alerts Editor, Current Urology Reports
2000-2004
Section Editor, Current Urology Reports (Prostatitis and Infections)2000-Present
Section Editor, Current Prostate Reports (Prostatitis and Infection) 2000-Present
Section Editor, Journal of EndoUrology (Survey)
2007-Present
Urology Journal ( reviewer )
Journal of Endourology ( reviewer )
Journal of Urology (reviewer)
British Journal of Urology (reviewer)
Neurourology and Urodynamics (reviewer)
National Committee Responsiblities:
American Urological Association:
Chair, Audio Visual Committee
Vice Chair, Audio Visual Committee
2008-2010
2007
Voting Audio Visual Committee Member
Abstract Committee Reviewer
Abstract Committee Team Leader
Annual Meeting Faculty Member
AUA BPH Course Director
Member of the AUA Education Council 2008- Present
2006- Present
National Institute of Heath
Task Force Member, Interstitial Cystitis Epidemiology Task Force Meeting
NIDDK/NIH, Bethesda, MD 10/29/03
Grant Reviewer, NIDDK CP Collaborative Network Grant Review Meeting,
3/17/03
Grant Reviewer, NIDDK IC Collaborative Network Grant Review Meeting,
3/18/03
Grant Reviewer, NCI Novel Technologies for InVivo Imaging Grant Review
Meeting 3/23/04
Consultant, NIDDK Prostate Basic and Clinical Research Strategic Planning
Meeting 7/10/07
Grant Reviewer, NIH, O’Brien Center for Urology 07/27-28/2009
L.
Philippino Chinese American Medical Association
Board of Governors, Member
2008-Present
National Association for Continence
Board Member
2008-Present
NY Academy of Medicine
Executive committee member of the Urology section.
2007-Present
BIBLIOGRAPHY
Peer Review Publications:
1.
2.
3.
4.
Te AE, Colombel M, Koo HP, Kaplan SA, Buttyan R, Olsson CA, Shabsigh R.
Castration-Induced Apoptosis in the Rat Penis. Surgical Forum 1992; 48: 724-725.
Te AE, Koo HP, Kaplan SA, Buttyan R, Olsson CA, Shabsigh R. Neurotrophic Factors
in the Diabetic Rat Penis. Surgical Forum 1993: 49: 758-760.
Kaplan SA, Te AE & Jacobs BZ. Urodynamic evidence of vesical neck obstruction in
men with " chronic non-bacterial " prostatitis and the therapeutic role of the endoscopic
incision of the bladder neck. J Urol. 1995; 152:2063-2065.
Te AE, Santarosa R, Buttyan R, Greene L, Koo HP, Kaplan SA, Olsson CA & Shabsigh
R. Neurotrophic Factors in the Rat Penis. J Urol.1994; 152:2167-2172.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
Kaplan SA, Te AE. , Blaivas JG: Urodynamic findings in patients with diabetic
cystopathy. J Urol. 1995; 153:342-344.
Kaplan SA, Te AE. Transurethral Electrovaporization of the Prostate (TVP): A novel
method of treating men with benign prostatic hyperplasia. Urology 1995; 45: 566-573.
Kaplan SA, Te AE. A comparative study of transurethral resection of the prostate using
a modified electrovaporizaing loop and transurethral laser vaporization of the prostate. J.
Urol. 1995; 154: 1785-90.
Kaplan SA, Te AE, Pressler LB, Olsson CA. Transition zone index (TZI): A novel
method of assessing benign prostatic hyperplasia: correlation with symptoms, uroflow
and detrusor pressure. J Urol. 1995; 154: 1764-69.
Bowers DL, Te A, Hibshoosh H, Sawczuk IS. Renal hemangiopericytoma. Case report
and review of the literature. Urol Int. 1995;55(3):162-6.
Kaplan SA, Bowers DA, Te AE, Olsson CA: Differential diagnosis of prostatism: 12year retrospective analysis of symptoms, urodynamics and satisfaction with therapy. J
Urol. 1996; 155: 1305-1308.
Kaplan SA, Olsson CA & Te AE: The American Urological Association symptom score
in the evaluation of men with lower urinary tract symptom: At 2 years of followup, does
it work?. J Urol. 155:1971-1974, 1996.
Kaplan SA, Ikeguchi EF, Santarosa RP, Meade D’ Alisera P, Hendriks J, Te AE &
Miller MI: Etiology of voiding dysfunction in men less than 50 years of age. Urology.
47: 836-839, 1996.
Kaplan SA, Santarosa RP & Te AE: Comparison of fascial and vaginal wall slings in the
management of intrinsic sphincter deficiency. Urology. 47: 885-889, 1996.
McKiernan JM, Kaplan SA, Santarosa RP, Te AE, Sawczuk IS: Transurethral
vaporization of bladder cancer. Urology 48(2): 207-10
Te AE, Santarosa R, Kaplan SA.:Electrovaporization of the prostate: electosurgical
modification of standard resection in 93 patients with benign hyperplasia. J Endourol
11(1):71-5, 1997.
Kaplan SA, Santarosa RP, Te AE: Transurethral electrovaporization of the prostate: one
year experience. Urology 48(6):876-81, 1996.
Kaplan SA, Santarosa RP, D’ Alisera PM, Fay BJ, Ikeguchi EF, Hendricks J, Te, AE:
Pseudodyssynergia (contraction of the external sphincter during voiding) misdiagnosed
as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option. J
Urol 157(6):2234-7, 1997
Kaplan SA, Reis RB, Cologna A, Suaid HJ, Martins ACP, Kohn IJ, Te AE: Intermittent
alpha-blocker therapy in the treatment of men with lower urinary tract symptoms.
Urology 52(1):12-16, 1998.
Kaplan SA, Te AE, Ikeguchi E, Santarosa RP: Safety and efficacy of alpha blockers in the
treatment of men over the age of 80 with benign prostatic hyperplasia. Br J Urol 1997
Dec;80(6):875-9
Kaplan SA, Reis RB, Staiman VB, Te AE: Is the ratio of transition zone to total prostate
volume higher in African-American men than in their Caucasian or Hispanic Counterparts?.
Br J Urol 1998, 82: 804-807
Kaplan SA, Reis RB, Kohn IJ, Ikeguchi EF, Laor E, Te AE, Martins ACP: Safety and
efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology 1999,
53:481-486.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
Kaplan SA, Reis RB, Kohn IJ, Shabsigh R, Te AE: Combination therapy using oral alpha
blockers and intracavernosal injection in men with erectile dysfunction. Urology 1998,
52(5): 739-43.
Kaplan SA, Laor E, Fatal M, Te AE: Transurethral resection of the prostate versus
transurethral electrovaporization of the prostate: a blinded, prospective comparative study
with 1 years followup. J Urology 1998, 159(2):454-8.
Reis RB, Te AE, Cologna AJ, Suaid HJ, Kaplan SA: Interstitial Thermometry in Men
Undergoing Electrovaporization of the Prostate. J Endourology 1999, 13 (1): 53-56.
Kaplan SA, Stifelman M, Avillo C, Reis RB and Te AE: Detrusor contraction duration
(DCD) may predict response to alpha blocker therapy for lower urinary tract symptoms.
Eur Urol 2000 Mar;37(3):314-7.
Kaplan SA, Te AE, Young GPH, Andrade A, Cabelin MA, Ikeguchi EF: Prospective
analysis of 373 consecutive women with stress urinary incontinence treated with a
vaginal wall sling: the Columbia- Cornell university experience, J Urol. 2000
Nov;164(5):1623-7.
Choi J, Ikeguchi EF, Lee SW, Choi HY, Te AE, Kaplan SA: Is the Higher Prevalence of
Benign Prostatic Hyperplasia Related to Lower Urinary Tract Symptoms in Korean Men
due to a High Transition Zone Index? Eur Urol. 2002 Jul;42(1):7-11.
Te AE: A modern rationale for the use of phenoxybenzamine in urinary tract disorders
and other conditions. Clin Ther. 2002 Jun;24(6):851-61; discussion 837.
Kaplan SA, Ghafar MA, Volpe MA, Lam JS, Fromer D, Te AE. PSA response to
finasteride challenge in men with a serum PSA greater than 4ng/ml and previous negative
prostate biopsy: preliminary study. Urology. 2002 Sep;60(3):464-8.
Te AE: Editorial Comment: Relief by botulinum toxin of voiding dysfunction due to
benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urol.
62(2): 264.
Te AE. The development of laser prostatectomy. BJU Int. 2004 Feb;93(3):262-5.
Kaplan SA, Volpe MA, Te AE. A prospective, 1-year trial using saw palmetto versus
finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J
Urol. 2004 Jan;171(1):284-8.
Te AE. Editorial Comment: Simultaneous administration of vardenafil and tamsulosin
does not induce clinically significant hypotension in patients with benign prostatic
hyperplasia. Urology. 2004 Nov;64(5):1003-1004.
Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, Malek RS.
Photoselective vaporization of the prostate for the treatment of benign prostatic
hyperplasia: 12-month results from the first United States multicenter prospective trial. J
Urol. 2004 Oct;172(4 Pt 1):1404-8.
Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassiumtitanyl-phosphate photoselective laser vaporization of prostate for treatment of benign
prostatic hyperplasia in men with large prostates. Urology. 2004 Dec;64(6):1155-9.
Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Photoselective laser vaporization
prostatectomy in men receivinganticoagulants.J Endourol. 2005 Dec;19(10):1196-8.
Kaplan SA, Walmsley K, Te AE. Tolterodine extended release attenuates lower urinary
tract symptoms in menwith benign prostatic hyperplasia. J Urol. 2005 Dec;174(6):22735.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
González RR, Fong T, Belmar N, Saban M, Felsen D, Te AE. Modulating bladder
neuroinflammation: RDP58, a novel anti-inflammatory peptide, reduces inflammation
and nerve growth factor production in experimental cystitis. J Urol 2005 Feb; 173(2):
630-4.
Lee R, Gonzalez RR, Te AE. The evolution of photoselective vaporization
prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia.
World J Urol. 2006 Sep;24(4):405-9.
Staskin DR, Te AE. Short- and long-term efficacy of solifenacin treatment in patients
with symptoms of mixed urinary incontinence. BJU Int. 2006 Jun;97(6):1256-61.
Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA. Impact of prostatespecific antigen level and prostate volume as predictors of efficacy in photoselective
vaporization prostatectomy: analysis and results of an ongoing prospective multicentre
study at 3 years. BJU Int. 2006 Jun;97(6):1229-33.
Monoski MA, Gonzalez RR, Sandhu JS, Reddy B, Te AE. Urodynamic predictors of
outcomes with photoselective laser vaporization prostatectomy in patients with benign
prostatic hyperplasia and preoperative retention. Urology. 2006 Aug;68(2):312-7.
El-Hakim A, Leung RA, Richstone L, Kim TS, Te AE, Tewari AK. Athermal Robotic
Technique of prostatectomy in patients with large prostate glands (>75 g): technique and
initial results. BJU Int. 2006 Jul;98(1):47-9.
Kaplan SA, Gonzalez RR, Te AE. Combination of Alfuzosin and Sildenafil is Superior
to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction.
Eur Urol. . Eur Urol. 2007 Jun;51(6):1717-23.
Te AE. Current state of the art photoselective vaporization prostatectomy: laser
therapy for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2007 Mar;10
Suppl 1:S2-5.
Lemack GE, Amundsen C, Badlani G, Griebling T, Peters K, Rodriguez L, Singla
A, Smith C, Sullivan M, Te A. Highlights from the combined Society of Urodynamics
and Female Urology, and International Society of Pelvic Neuromodulation annual
meeting. J Urol. 2007 Feb;177(2):691-5.
Te AE. Editorial Comment on the Manuscript, "Five-year follow-up of feedback
microwave thermotherapy versus TURP for clinical BPH: A prospective randomized
multicenter study”, Urol.2007 Jan; 69(1): 96-97
Te AE. Is transurethral microwave thermotherapy comparable to transurethral resection
for BPH? Nat Clin Pract Urol. 2007 Sep;4(9):478-9. Epub 2007 Jul 31.
Tewari AK, Bigelow K, Rao S, Takenaka A, El-Tabi N, Te A, Vaughan ED. Anatomic
restoration technique of continence mechanism and preservation of puboprostatic collar:
a novel modification to achieve early urinary continence in men undergoing robotic
prostatectomy. Urology. 2007 Apr;69(4):726-31.
Te AE. Current state of the art photoselective vaporization prostatectomy: laser therapy
for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2007 Mar;10 Suppl 1:S25.
Lee R, Saini R, Zoltan E, Te AE. Photoselective vaporization of the prostate using a laser
high performance system in the canine model. J Urol. 2008 Oct;180(4):1551-3. Epub
2008 Aug 16.
Te AE. Should vardenafil be used for the treatment of lower urinary tract symptoms
associated with BPH?. Nat Clin Pract Urol. 2008 Oct;5(10):536-7. Epub 2008 Aug 19.
53.
54.
55.
56.
57.
58.
59.
60.
Saini R, Gonzalez RR, Te AE. Chronic pelvic pain syndrome and the overactive
bladder: the inflammatory link. Curr Urol Rep. 2008 Jul;9(4):314-9.
O'Leary MP, Wei JT, Roehrborn CG, Miner M, BPH Registry and Patient Survey
Steering Committee (Te AE). Correlation of the International Prostate Symptom Score
bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice
setting. BJU Int. 2008 Jun;101(12):1531-5. Epub 2008 Apr 28.
Kaplan SA, Walmsley K, Te AE. Tolterodine extended release attenuates lower urinary
tract symptoms in men with benign prostatic hyperplasia. J Urol. 2008 May;179(5
Suppl):S82-5.
Schwartz MJ, Hwang DH, Hung AJ, Han J, McClain JW, Shemtov MM, Te AE, Sosa
RE, Vaughan ED Jr, Scherr DS. Negative influence of changing biopsy practice patterns
on the predictive value of prostate-specific antigen for cancer detection on prostate
biopsy. Cancer. 2008 Apr 15;112(8):1718-25.
Tewari A, Jhaveri J, Rao S, Yadav R, Bartsch G, Te A, Ioffe E, Pineda M, Mudaliar S,
Nguyen L, Libertino J, Vaughan D. Total reconstruction of the vesico-urethral junction.
BJU Int. 2008 Apr;101(7):871-7.
Lee R, Te AE, Kaplan SA, Sandhu JS. Temporal trends in adoption of and indications for
the artificial urinary sphincter. J Urol. 2009 Jun;181(6):2622-7. Epub 2009 Apr 16.
Rosen RC, Wei JT, Althof SE, Seftel AD, Miner M, Perelman MA; BPH Registry and
Patient Survey Steering Committee (Te AE). Association of sexual dysfunction with
lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH
Registry. Urology. 2009 Mar;73(3):562-6. Epub 2009 Jan 23.
Tan GY, El Douaihy Y, Te AE, Tewari AK. Scientific and technical advances in
continence recovery following radical prostatectomy. Expert Rev Med Devices. 2009
Jul;6(4):431-453
Invited Review Publications:
1.
2.
3.
4.
5.
6.
7.
Kaplan SA, Te AE: Uroflowmetry & Urodynamics.Urologic Clinics of North America
1995; 22: 309-20.
Te AE , Kaplan SA: Transurethral Electrovaporization of the Prostate (TVP): A
electrosurgical advancement of the standard TURP. Current Surgical Techniques in
Urology 1995; 8:1-9.
Te AE , Reis R, Kaplan SA: Transurethral Electrovaporization of the Prostate (TVP): A
novel modification of the standard TURP. Contemporary Urology 1995; 7:74-83.
Te AE, Kaplan SA: Electrovaporization of the Prostate. Current Opinion in Urology
1996; 6: 2-9.
Santarosa RP, Te AE, Kaplan SA: Minimally Invasive Procedures for Benign Prostatic
Hyperplasia. Mediguide to Urology 1996; 9:1-6
Te AE, Kaplan SA: Transurethral electrovaporization of the Prostate.Mayo Clin Proc
1998 Jul;73(7):691-5
Te AE and Kaplan SA: Transurethral electrovaporization of the prostate: the year in review.
Current Opinion in Urology 1997; 7:25-36.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
Santarosa RP, Te AE and Kaplan SA: Minimally invasive procedures for benign prostatic
hyperplasia: electrovaporization, lasers, heat therapy and stents. In: Mediguide for Urology.
Ed: Carson CC. 1996; 9:1-6.
Choi J, Ikeguchi EF, Te AE, Kaplan SA: Review of laser prostatectomy. Urology Review,
July, 1999.
Cabelin MC, Te AE, Kaplan SA: Benign prostatic hyperplasia: challenges for the new
millennium.Curr Opin Urol. 2000 Jul;10(4):301-6.
Cabelin MC, Te AE, Kaplan SA: Transurethral vaporization of the prostate: Current
Techniques. Current Urology Reports July 2000 1(2):116-123.
Kohn I, Te AE, Kaplan SA: Neuromodulations. AUA Updates; 2003.
Gonzalez R, Te AE: How do transurethral needle ablation of the prostate and treansurethral
microwave thermotherapy compare with transurethral prostatectomy. Current Urology
Reports. August 2003. 4(4): 297-306.
Gonzalez RR, Te AE. Overactive bladder and men: indications for anticholinergics. Curr
Urol Rep. 2003 Dec;4(6):429-35.
Sandhu J, Te AE. The Role of 5 AR Inhibition as Monotherapy in View of the MTOPS
Data. Current Prostate Reports. Volume 2, Issue 1; 2004.
Gonzalez RR, Te AE. Chronic prostatitis and sensory urgency: whose pain is it? Curr
Urol Rep. 2004 Dec;5(6):437-41.
Yang J, Te AE. Saw Palmetto and Finasteride in the Treatment of Category-III
Prostatitis/Chronic Pelvic Pain Syndrome. Curr Urol Rep. 2005 Jul;6(4):290-5.
Jaffe WI, Te AE. Overactive bladder in the male patient: epidemiology, etiology,
evaluation, and treatment. Curr Urol Rep. 2005 Nov;6(6):410-8.
Reddy BN, González RR, Te AE. The implications of cytokines in chronic prostatitis
and chronic pelvic pain syndrome. Curr Prostate Rep Nov 2005; 3(4): 189-94.
Gonzalez RR, Te AE. Is there a role for urodynamics in chronic nonbacterial
prostatitis? Curr Urol Rep. 2006 Jul;7(4):335-8.
Ng CK, Gonzalez RR, Te AE. Refractory overactive bladder in men: update on novel
therapies.Curr Urol Rep. 2006 Nov;7(6):456-61.
Te AE. The Next Generation in Laser Treatments and the Role of the GreenLight
High-Performance System Laser. Rev Urol. 2006;8 Suppl 3:S24-30.
Lebed, BD, Jafee WI, Te AE. Sexual Complications of Minimally Invasive Surgical
Therapy for Benign Prostatic Hyperplasia. Current Sexual Health Reports 2006, 3:76-82
Te, AE, Laser Prostatectomy Advance for the Prostate, Renal & Urology News, May
2006, pg 27
Lee R, Saini R, Kaplan SA, Te AE. A Review of Transurethral Microwave
Thermotherapy. AUA Update Series. Volume 26 Lesson 28 Page 277-284
Te AE. The PVP procedure for BPH: Long-term outcomes. Urology Times. January 1,
2007 Issue.
Review Publications:
1.
2.
3.
Te, AE: Literature Alerts, Current Urology Reports Volume 1, Issue 1; 2000
4.
5
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
Sandhu J, Te AE: Web Alerts, Current Urology Reports Volume 2, Issue 5; 2002
Te, AE: Literature Alerts, Current Urology Reports, Volume 4, Issue 1; 2003
Sandhu J, Te AE: Web Alerts, Current Urology Reports, Volume 4, Issue 1; 2003
50.
51.
52.
53.
54.
55.
56.
57.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
71.
73.
74.
75.
76.
77.
78.
79.
80.
Ng C, Te AE: Web Alerts, Current Urology Reports, Volume 6, Issue 5; 2005
Sandhu J, Te AE: Web Alerts, Current Prostate Reports, Volume 3, Issue 1; 2005
Ng C, Te AE: Web Alerts, Current Prostate Reports, Volume 3, Issue 4; 2005
Ng C, Te AE: Web Alerts, Current Prostate Reports,Volume 5, Issue 4; 2007
Winfield HN, Tally GG, Wong MYC, Te AE, Assimos DG, Conlin M, Duchene DA,
Cadeddu JA, Hemal A. Journal of Endourology. June 2007, 21(6): 563-573
Cadeddu JA, Hemal A. Survey of Endourology 2007 J Endourology 21(11): 1235-1248
Cadeddu JA, Hemal A. Survey of Endourology 2008 J Endourology 22 (11): 2415-2428
Cadeddu JA, Hemal A. Survey of Endourology 2008 J Endourology August 2008, 22(8):
1597-1608
81.
82.
83.
G.G. Tailly, H.N. Winfield, M.Y.C. Wong, A.E. Te, D.G. Assimos, M.J. Conlin, D.A.
Duchenne, J.A. Cadeddu, A.K. Hemal. Survey of Endourology 2008 J Endourology
22(5): 847-858.
Duchenne, J.A. Cadeddu, A.K. Hemal. Survey of Endourology. J Endourology. February
2009: 23(2): 209-222.
Duchenne, J.A. Cadeddu, A.K. Hemal. Survey of Endourology. J Endourology. June
2009, 23(6): 879-890
Book Chapters:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
Kaplan SA, Te AE: Bladder Dysfunction in Diabetes, In: Paulson, ed. Problems in
Urology; Neurourology and its Role in Urologic Diseases: Part I. Philadephia: J. B.
Lippincott Co., 6: 659-668. 1992.
Te AE , Kaplan SA: Pharmaceutical Treatment of BPH and its effect on indications for
prostate surgery. In: Surgical Technology International III: Endourology. San Francisco:
Universal Medical Press, Inc.1994.
Te AE, Kaplan SA: Urodynamics and BPH. In: Kirby RS, McConnell JD, Fitzpatrick
JM, Roehrborn CG, Boyle P, eds. Textbook of Benign Prostatic Hyperplasia. Oxford: Isis
Medical Media, LTD., 187-198. 1996.
Te AE, Kaplan SA: Prostatic Endoprosthetics. In: Kirby RS, McConnell JD, Fitzpatrick
JM, Roehrborn CG, Boyle P, eds. Textbook of Benign Prostatic Hyperplasia. Oxford: Isis
Medical Media, LTD. 453-462.1996.
Te AE, Kaplan SA: Electrovaporization of the Prostate: Advance Application of
Electrosurgical Principles to the Treatment of Benign Prostatic Hyperplasia. In: Kirby
RS, O’Leary MP, ed. Recent Advances in Urology 7. London: Churchill Livingston,
1998.
Santarosa RP, Te AE, Kaplan SA: Transurethral resection, incision and ablation of the
prostate. In: Graham SD, ed. Glenn’s Urologic Surgery, 5th edition. Philadephia: Lippincott,
Williams and Wilkins. 921-931.1998.
Te AE, Santarosa RP, Kaplan SA: Tranurethral Electrovaporization of the Prostate. In:
Resnick MI, Thompson IM, ed. Surgery of the Prostate. London: Churchill Livingston.295307. 1998.
Te AE, Kaplan SA: Electrovaporization Principles. In: Narayan P, ed. Benign Prostatic
Hyperplasia. London: Churchill Livingstone, 325-334. 2000.
Kohn IJ, Te AE and Kaplan SA: Urodynamics of prostatitis. In: Nickel JC ed., Textbook of
prostatitis. Oxford: Isis Medical Media, LTD. 2000.
Ikeguchi EF, Te AE, Choi J, Kaplan SA: Bladder Outlet Obstruction in Males. In: Appel
RA,ed. Current Clinical Urology: Diagnosis and Treatment. Totowa, NJ: Humana Press Inc.
2000.
Te AE, Ikeguchi EF, Kaplan SA: Transurethral Electrovaporization of the Prostate. In:
Recent Advances in Endourology. Vol. 2/ Treatment of BPH. Tokyo: Springer-Verlag. 157-166, 2000.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
Te AE, Kaplan SA: Complication of Minimally Invasive Surgery for BPH. In: Taneja
SS, Smith RB, Ehrlich RM, ed. Complication of Urologic Surgery, 3rd edition.
Philadelphia: W. B. Saunders, 244-256, 2001.
Cabelin M, Te AE and Kaplan SA: Urogenital physiology. In: Gonzalez, Myers, Edelman,
Leiberman and Downey, ed., Physiological Basis of Rehabilitation Medicine.191-208, 2001.
Te AE, Kaplan SA: Electrovaporization of the Prostate. In: Miller PD, Eardley I,Kaplan SA,
ed. Benign Prostatic Hyperplasia: Laser and Heat Therapy.. London: Martin Dunitz. 2001.
Volpe M, Ghafar MA, Te AE: Diagnosis and Management of Obstruction after AntiIncontinence Surgery. In: Carlin BI and Leong FC, ed. Female Pelvic Health and
Reconstructive Surgery. New York, NY: Marcel Dekker, Inc. 2002.
Sandhu JS, Te AE: Open Prostatectomy. In: Kaplan SA and Cabelin M, ed. Atlas of
Urologic Clinics of North America. Philadelphia, PA: W. B. Saunders. April 2002.
Cabelin MA, Ghafer MA, Te AE, Kaplan SA: Transurethral Vaporization of the Prostate.
In: Kaplan SA and Cabelin M, ed. Atlas of Urologic Clinics of North America.
Philadelphia, PA: W. B. Saunders. 45-49, 2002.
Sandhu J, Te AE. Benign Prostatic Hyperplasia (BPH). In: Martini L, ed. Encyclopedia
of Endocrine Diseases: 4 Volumes. San Diego, Ca. Academic Press 2004
Te AE, Ikeguchi EF, Choi J, Kaplan SA: Urodynamics and benign prostatic hyperplasia. In:
Kirby RS, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P., ed. Textbook of benign
prostatic hyperplasia. 2nd Edition. Oxford: Isis Medical Media Ltd. 2005, pg 241-253.
Hyman MJ, Te AE: Stents, TUIP and Electrovaporization. In: Kaplan SA, Atala A and
Partin A, ed. Minimally Invasive Alternatives in Urology. New York, NY: Marcel
Dekker, Inc. 2005.
Gonzalez RR, Lee R, Sandhu JS, Te AE. Laser Prostatectomy In Atlas of the Prostate,
Eds. Scardino PT, Slawin K. 3rd Edition, 2006.
21.
Gonzalez RR, Tyagi T, Te AE. Neurologic Disorders. In: Cardozo L and Staskin
D, Ed. Textbook of Female Urology and Gynecology.United Kingdom. 2006. pg 565582.
Schiff JD, Te AE. Electrosurgery of the Prostate: Improvements in TURP-Treatment and
Outcomes. In: Smith AD et al, Ed. Smiths’ Textbook of Endourology. 2nd Edition 2007.
pg.645-651
Lee R, Sandhu J, Gonzalez RR, Te AE. Laser Prostatectomy. In: Smith AD et al, Ed.
Smiths’ Textbook of Endourology. 2nd Edition 2007. pg. 617- 626.
25.
Te AE. Benign Prostatic Hyperplasia. In: Morey A. Shokes DA, Ed. The
American Urological Association Educational Review Manual in Urology. 1st Edition
2007.
Ulchaker JC, Te AE. Benign Prostatic Hyperplasia. In: Morey A. Shokes DA, Ed. The
American Urological Association Educational Review Manual in Urology. 2nd Edition
2009.
Multimedia Publications:
1.
2.
3.
4.
5.
6.
7.
8. .
9.
10.
Te AE, Kaplan SA: Transurethral electrovaporization of the prostate. Endourology on
CD-ROM. Vol. 1, Editors; Paoletti P & Benelli R, IPE Mutimedia, Firenze, Italty.1997.
Te AE, Ghafar MA, Merriweather T, Volpe MA, Ikeguchi E, Kaplan SA. Nomogram
and urodynamic predictors of urinary retention in men with BPH and Bladder Outlet
Obstruction. Poster #1096.Annual AUA Meeting 2001 CD ROM of Top 120 Poster
Presentation.
Kaplan SA, Blute M, Bruskewitz RC, Te AE, Larson TR, Utz W, Ugarte R, Mayer R:
Long term efficacyand durability in 345 patients treated with transurethral microwave
thermotherapy for benign prostatic hyperplasia: five year results. Poster #1153 .Annual
AUA Meeting 2002 CD ROM of Top 120 Poster Presentation.
González RR, Te AE. Photoselective vaporization of the prostate with the 80 watt
quasicontinuous KTP laser for the treatment of benign prostatic hyperplasia. DVD
Video. American College of Surgeons, Cine Clinics, Clinical Congress, October 12,
2004, New Orleans, LA CC I: Urological surgery CD Collection Cat Number VS1090.
Sandhu JS, Te AE, Eilber KS. The Male Bulbourethral Sling. Society for Female
Urology and Urodynamics. SUFU Annual Meeting, Grand Bahamas. Best Video Award.
2005
Sandhu JS, Te AE. Photoselective Vaporization of the Prostate - The Vaporization
Incision Technique for Large Volume Prostates. AUA Annual Meeting. 2005 J Urol
2005, 173(4): 366.
Te AE, Gonzalez R, Sandhu JS Photoselective Vaporization of the Prostate - The
Vaporization Incision Technique (PVP-VIT) in DVD titled, Il Laser Per Il Trattamento
Dell’Iperplasia Prostatica Benigna, Editor, Roberto Benelli, Italy, 2005.
Te AE Laser Prostatectomy for the Treatment of BPH Q & A from Prostatic Hyperplasia
(BPH) 2006: Are We Treating a New Disease? In Topics in Urology Audio Series.
Moderator: P Rogers. Oakstone Medical Publishing. CME Accredited Series. Fall 2006.
Te AE. Urodynamics and BPH slide set. Timely Topics in Medicine. Prious Sceince.
www.ttmed.com.12/12/07
Te AE. Urodynamcis and BPH article. Timely Topics in Medicine. Prious Sceince.
www.ttmed.com.12/12/07
Abstracts:
1.
2.
3.
4.
Te AE, Buttyan R, Koo HP, Greene LA, Kaplan SA, Olsson CA & Shabsigh R:
Abundant expression of nerve growth factor (NGF) in the rat penis, a developmental
study. J Urol. 147:239A, 1992.
Te AE, Buttyan R, Koo HP, Shabsigh R, Olsson CA & Kaplan SA: Nerve growth factor
in diabetic cystopathy. J Urol. 147:350A, 1992.
Koo HP, Buttyan R, Te AE, Kaplan SA, Olsson CA & Shabsigh R: Neurotrophin
expression in diabetic rat penis: a new insight into pathogenesis of erectile dysfunction. J
Urol. 147:240A, 1992.
Shabsigh R, Buttyan R, Koo HP, Kaplan SA, Olsson CA & Te AE: Expression of
neurotrophins: nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and
ciliary neurotrophic factor (CNTF) in the rat penis. J Urol. 147:318A, 1992.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
Brown W, Te AE, Olsson CA & Benson MC: Management of complications of continent
urinary diversions. J Urol. 147:390A, 1992.
Te AE, Buttyan R, Koo HP, Olsson CA & Kaplan SA: Nerve growth factors in diabetic
cystopathy. Neurourology and Urodynamics. 11(4):303, 1992.
Te AE, Buttyan R, Koo HP, Shabsigh R, Olsson CA & Kaplan SA: Nerve growth factors
in diabetic cytopathy. Diabetes. 41(Sup 1):140A, 1992.
Kaplan SA, Te AE & Blaivas JG: Urodynamic findings in patients with diabetes and
voiding symptoms: surprising results. International Continence Society. 22nd Ann. Mtg.
Abstract 115, 1992.
Te AE, Buttyan R, Koo HP, Kaplan SA, Olsson CA & Shabsigh R: Neurotrophic Factors
in the diabetic rat penis: an extended study. J Urol. 149:247A, 1993.
Santarosa RP, Te AE, Koo HP, Buttyan R, Kaplan SA, Olsson CA & Shabsigh R:
Androgen Deprivation and Apoptosis in Rat Erectile Tissue. J Urol. 151:494A, 1994.
Te AE, Olsson CA & Kaplan SA: Use of the AUA-BPH treatment guidelines in men
with symptomatic benign prostatic hyperplasia (BPH): At one year, is it effective?. J
Urol. 151:507A, 1994.
Shabsigh R, Te AE, Koo HP, Kaplan SA, Olsson CA & Shabsigh: Localization of nerve
growth factor beta (NGF) in the rat penis by in-situ hybridization. Society for Basic
Urologic Research Fall Symposium, Rochester, MN, 1991.
Te AE, Colombel M, Koo HP, Kaplan SA, Buttyan R, Olsson CA & Shabigh R:
Castration- induced apoptosis in the rat penis. ACS Annual Mtg. Chicago Il, 1992.
Shabsigh R, Te AE & Fisch H: Cavernous electromyography as an indication of adequate
smooth muscle relaxation during duplex ultrasonography. 5th World Meeting on
Impotence. Milan, Italy, 1992.
Te AE, Buttyan R, Koo HP, Greene L, Kaplan SA, Olsson CA & Shabsigh R:
Neurotrophins in the rat penis. 5th World Meeting on Impotence. Milan, Italy, 1992.
Santarosa RP, Te AE, Koo HP, Raymond J, Columbel M, Olsson CA, Buttyan R &
Shabsigh R: Testoterone sensitivity of the erectile tissue of the rat penis to castration. 7th
World Meeting on Impotence. Singapore, ISIR, 1994.
Te AE, Kaplan SA, Dann JA. Transurethral electrovaporization of the prostate (TVP): A
novel method for treating men with benign prostatic hyperplasia. J Urol. 1995; 153:
436A.
Te AE, Santarosa R, Kaplan SA. Transurethral electrovaporization of prostate (TVP): A
modification on the standard TURP. J Endourology 1995; 9: S58.
Kaplan SA, Santarosa RP, Te AE: Electrovaporization of the prostate for symptomatic
benign prostatic hyperplasia: the 1 year experience. J Urol. 1996, 155(5):405A.
Reis RB, Cologna AJ, Suaid HJ, Kaplan SA, Te AE: Electrovaporzation of the prostate
(VAP): a comparison of roller electrode configurations for resecting prostate tissue. J Urol.
1996, 155(5):406A.
Laor E, Kaplan SA, Te AE, Tolia BM and Reid RE: Laser vaporization of ‘large” prostate
glands: long term follow - up. J Urol. 1996, 155(5):706A.
Reis RB, Cologna AJ, Suaid HJ, Te AE and Kaplan SA: Interstitial thermometry in men
undergoingelectrovaporization: is it safe? J Urol. 1996, 155(5):707A.
Kaplan SA, Santarosa RP, Te AE: The incidence of hypertension in men with benign
prostatic hyperplasia. XIIth European Urology Association, Paris, 1996.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
39.
Kaplan SA, Laor E, Te AE: Transurethral rsection of the prostate (TURP) versus
electrovaporization of the prostate (VAP): a prospective, blinded comparative study of
the treatment of benign prostatic hyperplasia (BPH). XXIIth European Urology
Association, Paris, 1996.
Avillo C, Stifelman M, Te AE, Sandler P and Kaplan SA: The urodynamic parameter:
detrusor contraction duration (DCD) predicts response to alpha blocker therapy for lower
urinary tract symptoms (LUTS). J Urol.1997, 157(4): 136.
Te AE, Laor EL, Kaplan SA, Babayan R, Noble M, Mbust W, Bruskewitz R, Whitfield
HN: Transurethral resection of the prostate (TURP) versus vaporization of the prostate
utilizing a vaporizing loop (TVLOOP): a multicenter, blinded, prospectie comparative
study. J Urol.1997, 157(4): 313.
Te AE, Laor E, and Kaplan SA: Transurethral resection of the prostate (TURP) versus
transurethral electrovaporization of the prostate (TVP): a blinded, prospective comparative
study with 1 year follow - up. J Urol.1997, 157(4): 313.
Pressler LB, Santarosa RP, Te AE and Kaplan SA: The incidence of hypertension (HTN) in
a population of men with benign prostatic hyperplasia (BPH): analysis based on the AUA
symptom score and race. J Urol.1997, 157(4): 371.
D’Alisera PM, Stifelman M, Kohn I, Te AE, Weiner DM, Kaplan SA: Correlation of
lower urinary tract symptom (LUTS) severity by International Prostate Symptom Score
(IPSS) and erectile dysfunction (ED) in men over 50 years of age. J Urol. 1998, 159(5):
103.
Reis RB, Suaid HJ, Cologna AJ, Te AE, Kaplan SA: Men with lower urinary tract
symptoms (LUTS) and inguinal hernias (HERN) have significantly greater bladder outlet
obstruction (BOO) than men with LUTS alone. J Urol. 1998, 159(5): 139.
Reis RB, Suaid HJ, Cologna A, Martins ACP, Te AE, Kaplan SA: Intermittent therapy
with alpha blocker, alfuzosin. J Urol. 1998, 159(5): 331.
Nejat RJ, Ikeguchi EF, Te AE, Reis RB, Kaplan SA: Electrovaporization of the prostate
utilizing the roller ball and/or vaporizing loop for the symptomatic benign prostatic
hyperplasia (BPH): The 4- year Columbia experience. J Urol 1999, 161(4): 391.
Ries RB, Martins ACP, Cologna A, Junior ST, Te AE, Kaplan SA: Long term durability
of intermittent alpha blockade in the treatment of lower urinary tract symptoms (LUTS). J
Urol 2000, 163(4): 1362.
Choi J, Ikeguchi EF, Lee SW, Choi HY, Te AE, Kaplan SA: Characterization of lower
urinary tract symptoms and prostate parameters in Asian men compared to Caucasians,
Hispanics and African - Americans. J Urol 2000, 163(4): 1110, 250.
Cabelin MA, Te AE, Ikeguchi EF, Andrade AJ, Young GPH, Kaplan SA: Prospective
analysis of 327 women with stress urinary incontinence treated with vaginal wall sling: a
multicenter experience. Neurourology & Urodynamics 2000, 19(3):323-364.
Cabelin MA, Hyun G, Te AE, Meade D’Alisera P, Shabsigh R, Kaplan SA. Increased
incidence of depressive symptoms in women with stress urinary incontinence.
Neurourology & Urodynamics 2000, 19(3):323-364.
Volpe MA, Te AE, Kaplan SA. A prospective trial using saw palmetto versus finasteride
in the treatment of chronic nonbacterial prostatitis. J Urol 2001, 165(5): 27.
Te AE, Ghafar MA, Merriweather T, Volpe MA, Ikeguchi E, Kaplan SA. Nomogram
and urodynamic predictors of urinary retention in men with BPH and Bladder Outlet
Obstruction. J Urol 2001, 165(5): 267.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
Cooper K, Littlejohn JO, Te AE, Kaplan SA: Disappointing long term results of
transvaginal bone anchors
in the treatment of stress urinary incontinence (SUI): The
3-year New York Presbyterian hospital experience. J Urol 2002 , 167(4): 78.
Rodgers JM, Te AE, Ghafar M, Kaplan SA, Zaontz MR, Packer M, Dean GE:
Glibenclamide enhances stretch-activated contrationin rat bladders and shows protective
effects in human diabetic cystopathy. J Urol 2002, 167 (4): 42.
Kaplan SA,Te AE: Electrovaporization of the prostate utilizing the roller ball and/or
vaporizing loop for symptomatic benign prostatic hyperplasia ( BPH): the 7 year
Columbia experience in 650 consecutive men. J Urol 2002, 167 (4): 296.
Kaplan SA,Te AE: Pressure/ flow evaluation of ethnically diverse men treated by
minimally invasive surgical therapies for BPH: The New York Presbyterian Hospital
Experience. J Urol 2002, 167 (4): 366.
Gonzalez RR, Sher K, Fong T, Te AE: RDP58 reduces bladder inflammation in a murine
model of acute inflammatory cystitis. J Urol 2003, 169 (4): 68.
Gonzalex RR, Sher K, Fong T, Te AE: The effect of DMSO on bladder inflammation in
a murine model of acute inflammatory cystitis. J Urol 2003, 169 (4): 69.
Sandhu SS, Vanderbrink BA, Egan C, Kaplan SA, Te AE: High-power KTP
photoselective laser vaporization prostatectomy for the treatment of benign prostatic
hyperplasia in men with large prostates. J Urol 2003, 169(4): 393.
Te AE, Malloy TR, Stein BS, Ulcahker JC, Hai MA, Nseyo UO, Malek RS:
Photoselective laser vaporization of the prostate (PVP) for the treatment of benign
prostatic hyperplasia: The first multicenter prospective trial. J Urol 2003, 169(4): 465.
Cooper K, Te AE, Kaplan SA: Long term safety and efficacy in 147 patients treated
with prostate stents for benign prostatic hyperplasia: 12 year results. J Urol 2003,
169(4):465.
Sandhu SS, Vanderbrink BA, Egan C, Kaplan SA, Te AE: High-power KTP
photoselective laser vaporization prostatectomy for the treatment of benign prostatic
hyperplasia in men with large prostates. World Congress of Endourology, Toronto,
9/2003
Kaplan, SA, Walmsley K, Te AE. Use of muscurinic receptor antagonist as monotherapy
in men with lower urinary tract symptoms who failed previous therapy with alpha
blockers. J. Urol. 2004 171(4):243
Te AE, Kaplan SA: Dutasteride provides improvement in urodynamic parameters over 2
years: Analysis of data from the phase III dutasteride studies. J Urol. 2004 171(4): 359
Malloy TR, Stein BS, Ulcahker JC, Nseyo UO, Hai MA, Malek RS, Te AE:
Photoselective laser vaporization of the prostate (PVP) for the treatment of benign
prostatic hyperplasia: 24-month results from a prospective multicenter clinical trial. J
Urol. 2004 171(4): 399.
Sandhu JS, Ng CK, Gonzalez R, Kaplan SA, Te AE: High-power KTP photoselective
laser vaporization prostatectomy for the treatment of benign prostatic hyperplasia in men
with large prostate: The New York Presbyterian series of 64 patients. J Urol. 2004
171(4): 400.
Te AE, Sandhu JS, Gonzalez R, Egan C, Kaplan SA, Te AE: High-power KTP
photoselective laser vaporization prostatectomy (PVP) versus transurethral
electrovaporization of the prostate (TVP) for the treatment of benign prostatic
hyperplasia ( BPH): A prospective comparative trial. J Urol. 2004 171(4): 402.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
Okeke Z, Walmsley K, Te AE, Kaplan SA: Sexual function in ethnically diverse men
with Category III Prostatitis/ Chronic Pelvic Pain Syndrome. J Urol 2004 171(4): 60.
Monoski MA, Sandhu JS, González RR, Te AE. Urodynamic predictors of success with
photoselective laser vaporization prostatectomy in patients with benign prostatic
hyperplasia and preoperative retention. J Urol 2005, 173(4): 354.
Te AE, Sandhu JS, Reddy B, Ng CK, González RR, Kaplan SK. The first 200 patients
treated with high power KTP photoselective laser vaporization prostatectomy: the New
York Presbyterian experience. J Urol 2005, 173(4): 423.
Sandhu JS, Te AE. Electrosurgical transurethral resection of the prostate: Evaluating the
training gap. J Urol 2005, 173(4): 34.
Sandhu JS, Te AE. Photoselective vaporization of the prostate-The vaporization incision
technique for large volume prostates. J Urol 2005, 173(4): 366.
Te AE, Malloy TR, Stein BS, Ulcahker JC, Nseyo UO, Hai MA. Impact of prostate
specific antigen and prostate volume as predictors of efficacy outcomes in photoselective
vaporization prostatectomy (PVP): Analysis and results of ongoing prospective
multicenter study at three years. J Urol 2005, 173(4): 421.
Malloy TR, Sandhu JS, Smith AL, Reddy B, Harryhill JF, Kaplan SA, Te AE.
Photoselective vaporization of the prostate (PVP) in anticoagulated patients: A
multicenter retrospective evaluation of feasibility. J Urol 2005, 173(4): 423.
Stein BS, Te AE, Malloy TR, Ulcahker JC, Nseyo UO, Hai MA. Factors influencing
efficacy outcomes in photoselective vaporization prostatectomy (PVP): Analysis and
results of ongoing prospective multicenter study at three years. Urol 2005,
66(Supplement 3A):17-18
Reddy B, Gonzalez RR, Sandgu JS, Kaplan SA, Te AE. High power KTP photoselective
vaporization prostatectomy: The New York Presbyterian Experience. . Urol 2005,
66(Supplement 3A): 19.
Kaplan SA, González RR, Ogiste J, Te AE. Combination of an alpha-blocker, alfuzosin
SR and a PDE-5 inhibitor, sildenafil citrate, is superior to monotherapy in treating lower
urinary tract symptoms (LUTS) and sexual dysfunction. J Urol 2006, 175(4): 528.
Kaplan SA, Kaplan JD, González RR, Te AE. The use of a voiding diary to evaluate
urinary frequency and nocturia is a better indicator than the IPSS in assessing alphablocker efficacy in men with lower urinary tract symptoms (LUTS) in men with benign
prostatic hyperplasia (BPH). J Urol 2006, 175(4): 438.
González RR, Reddy B, Chen J, Staskin DR, Te AE. Effects of short-term estrogen
deprivation on experimental bladder inflammation. J Urol 2006, 175(4): 61-2.
Penson D, Litwin MS, Payne R, Te AE, Metzger C, Wei JT Do Socioeconomic
Characteristics Play a Role in Treatment Choice for BPH? J Urol 2006, 175(4): 2.
Monoski MA, Gonzalez RR, Sandhu JS, Reddy B, Te AE. Urodynamic predictors of
outcomes with photoselective laser vaporizationprostatectomy in patients with benign
prostatic hyperplasia and preoperative retention. 2006 SUFU Annual Meeting . Grand
Bahamas 2006 February
Ricardo R. Gonzalez, Balaji N. Reddy, Jaspreet S. Sandhu, Steven A. Kaplan, and Alexis
E. Te, High-power KTP photoselective laser vaporization prostatectomy:
The New York Presbyterian Experience. 2006 SUFU Annual Meeting. Grand Bahamas
2006 February.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
Balaji N. Reddy, R. R. Gonzalez, S. A. Kaplan, and A.E. Te, High-Power KTP
Photoselective Vaporization Prostatectomy (PVP): The Cornell Experience. American
Society of Laser Medicine and Surgery Annual Meeting 2006, Boston, Massachusetts
ASLMS. April 6, 2006
Te AE, Gonzalez RR, Reddy B, and Kaplan SA. Photoselective laser vaporization
prostatectomy-vaporization incision technique for large prostates. Western Section
American Urological Association, Maui, HI October 22, 2006
Te AE, Yang JH, Gonzalez RR, Reddy B, Xi Z, Madhu M, and Kaplan SA. Safety and
efficacy of photoselective laser vaporization of the prostate for benign prostatic
hyperplasia (BPH) in men over 80 years. Western Section American Urological
Association, Maui, HI October 22, 2006
Roehrborn CG, Penson D, Te AE, Wei JT, Nuckolls J. Why Men on Watchful Waiting
for LUTS/BPH Start Medical Therapy: Findings from the USA BPH Registry & Patient
Survey, Annual SIU Meeting, 2006, South Africa 11/13/06
Hung AJ, Schwartz MJ, Hwang DH, McClain JW, Han J, Shmetov MM, Te AE, Sosa
RE, Vaughan ED, Scherr DS. Changes in practice patterns and outcomes of transrectal
ultrasound-guided biopsy. 2007 J Urol. 177(4): 203 Suppl.
Roehrborn CG, Wei JT, Steers WD, Miner M, Seftel AD, Te AE, BPH Registry Steering
Committee. Health-related quality of life is the main predictor of progression to benign
prostatic hyperplasia related surgery: outcomes data from the BPH registry & patients
survey. 2007 J Urol. 177(4): 495 Suppl.
Kaplan SA, Fisch H, Berriman SJ, Saini R, Lee R, Te AE, Central obesity as measured
by waist circumference is predictive of severity of lower urinary tyract symptoms, sexual
dysfunction, and componenets of the metabolic syndrome.. 2007 J Urol. 177(4): 497
Suppl
Rao S, Martinez-Salamanca JI, Ramanathan R, Mandhani A, Leung R, Te AE, Berryhill
R, Horninger W, Takennaka A, Vaughan ED, Tewari A. Total reconstruction technique
of the continence mechanism following robotic prostatectomy. 2007 J Endourology 21
(Suppl 1): P28.
Rao S, Ramanathan R, Martinez-Salamanca JI, , Mandhani A, Te AE, Bartsch G, Tewari
A. Total continence outcomes in patients undergoing robotic prostatectomy- A
comparison of three techniques. 2007 J Endourology 21 (Suppl 1): P28.
Rao S, Takennaka A, Martinez-Salamanca JI, Li P, Leung R, Mandhani A, Ramanathan
R, Bartsch G, Te AE, Tewari A. Total reconstruction technique of the continence
mechanism following robotic prostatectomy. 2007 J Endourology 21 (Suppl 1): A229.
Saini R, Te AE, Tewari AK, Rao AR, Kaplan SA. Predictive factors for post
prostatectomy (RP) urinary incontinence (UI) in men with pre-operative lower urinary
tract symptoms ( LUTS): a pilot study. Neurourology & Urodynamics 2007 26(7): 1105
Suppl
Lee R, Saini R, Te AE. Photoselective vaproization of hte prostate (PVP) using the
Greenlight high performance system (HPS) in the canine model. Neurourology &
Urodynamics 2007 26(7): 1094 Suppl.
Monoski M, Te AE, Kaplan SA. Lower urinary tract symptoms associated with
obstructive sleep apnea improve after treatment with continuous positive airway pressure.
Neurourology & Urodynamics 2007 26(7): 1063 Suppl.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
Zoltan E, Lee RR, Saini R, Egan CA, Kaplan SA, Te AE. Comparative evaluation of the
high power 532 nm laser systems, 120 Watt (HPS) VS 80 Watt (KTP), for photoselective
vaporization of the prostate (PVP) of large glands with vaporization incision technique
(VIT) J Urol. 2008 179 (4): 626 Suppl.
Gonzalez RR, Soni SD, Reddy B, Madhu M, Kaplan SA, Te AE. Octogenarians with
symptomatic benign prostatic hyperplasia (BPH) have similar outcomes after
photoselective vaporization of the prostate (PVP) compared to a younger cohort despite
increased comorbidities J Urol. 2008 179 (4): 631 Suppl.
Kaplan SA, Zoltan E, Te AE. Safety and efficacy of tolterodine, solifenacin, and
darifenacin in men with oower urinary tract symptoms (LUT) on alpha-blockers with
persistent overactive bladder symptoms (OAB) J Urol. 2008 179 (4): 701 Suppl.
Rao S, Tu J, Jhaveri J, Yadav R, Leung R, Martinez-Salamanca JI, Takenaka A, Te AE,
Bartsch G, Vaughan ED, Tewari A. Distribution of peri-prosatic nerves in the fascial
planes around the prostate- Implications for the technique of nerve sparing radical
prostatectomy. J Urol. 2008 179 (4): 228 Suppl.
Jhaveri J, Chhabra P, Te AE, Takenaka A, Tu J, Yadav R, Rao S, Leung R, Salamanca J,
Bartsch G, Menon A, Vaughan ED, Tewari A. Grades of robotic nerve sparing J Urol.
2008 179 (4): 488 Suppl.
Chung DE, Lee R, Te AE. Transurethal Laser Enucleation of the Prostate (TLEP) - 2Year Experience J Urol. 2009 181 (4):130 Suppl.
Tan GY, Jhaveri JK, Scott A, Dorsey PJ. Herman M, Te AE, Rao S, Tewari A.
Biomechanical foundations for accelerated continence recovery after robotic-assisted
radical prostatectomy J Urol. 2009 181 (4): 361 Suppl.
Te AE, Chung DE, Lee RI, Kaplan SA. Near-infrared Spectroscopy (NIRS) for
Application in Urology J Urol. 2009 181 (4): 601 Suppl.
Lee R, Te AE, Kaplan SA, Sandhu JS. Temporal Trends in Adoption of and Indications
for the Artificial Urinary Sphincter (AUS) J Urol. 2009 181 (4): 617 Suppl.
Kaplan SA, Chung DE, Sandhu JS, Te AE. Generic substitutes are neither as safe nor
effective as branded medications: experience in men treatred for lower urinary tract
sysmptoms. J Urol. 2009 181 (4): 649 Suppl.
Kaplan SA, Chung DE, Sandhu JS, Te AE. Safety and efficacy concerns in switching
patients with overactive bladder (OAB) symptoms from branded to generic
anticholinergic medications. J Urol. 2009 181 (4): 675 Suppl.
Chung DE, Te AE, Staskin DR, Kaplan SA. Efficacy and safety of tolterodine extende J
Urol. 2009 181 (4): 488 Suppl.d release and dutasteride in male overactive bladder
(OAB) patients with prostates = 30 grams. J Urol. 2009 181 (4): 697 Suppl.
Chung DE, Te AE, Staskin DR, Kaplan SA. Efficacy and safety of tolterodine extended
release and dutasteride in male OAB patients with prostates ≥ 30 grams. Neurourology
Urodynamics. 2009 28 (2):161.
Chung DE, Lee RK, Scofield S, Te T, Te AE. KTP laser photoselective vaporization of
the prostate: 6-year experience. Neurourology Urodynamics 2009 28(2): 161.
Video Presentations and Publications:
1. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate. J Urol.1995; 153: 48A.
2. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate. Video Urology Times.
1995.
3. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate., WHO-BPH Meeting.
1996
4. Te AE, Kaplan SA: Transurethral electrovaporization of the prostate., WHO-BPH Meeting.
1997
5. Te AE, Gonzalez: Photoselective Vaporziation of the Prostate with the 80 Watt
Quasicontinous KTP Laser for the treatment of BPH., American College of Surgeons Annual
Meeting. The 55th Cine-Clinic. 2004
6. Sandhu JS, Te AE. Photoselective vaporization of the prostate-The vaporization incision
technique for large volume prostates. J Urol 2005, 173(4): 366.
7. Chung DE, Lee R, Te AE. Transurethal Laser Enucleation of the Prostate (TLEP) - 2-Year
Experience J Urol. 2009 181 (4):130
Lectureships and Presentations: (selected 40 out of 130 events)
1. “Transurethral Electrovaporization of the Prostate”, Faculty Lecturer and Moderator, 1995
Annual Meeting of Society of Minimally Invasive Surgery, Portland, Oregon, 9/23/95.
2. “Transurethral Electrovaporization of the Prostate”, 1995 Annual International Meeting of
the ESWL and Endourology Society, Jeruselum, Israel, 11/25/95.
3. “Medical Therapies for BPH”. Faculty Lecturer. 1996 Annual Philippine Chinese Medical
Association, New York, NY 7/7/96.
4. “Electrovaporization of the Prostate”, Visiting Professor, Grand Rounds Lecture, University
of Santo Tomas Medical School, Manilla, Philippines, 9/25/96.
5. “Transurethral Electrovaporization of the Prostate”, Keynote Visiting Professor, 1996
Annual Japanese Urological Association Meeting, Tokyo, Japan, 12/12/96.
6. “New Therapies in BPH”. Faculty Lecturer. 1997 Annual Philippine Medical Association
Meeting in US, New York, NY, 5/24/97.
7. “New Approaches to Management of the Overactive Bladder” Faculty Lecturer. 1998
Martin Stone OB/GYN Society Meeting. New York Academy of Medicine, New York, NY
10/23/98.
8. “Old versus New: Transvaginal Suspensions and Transvaginal Slings” The New York
Academy of Medicine, NY, NY 7/10/99.
9. “Counterpoint: The holmium laser resection of the prostate”, NY Section AUA Annual
Meeting, South Africa 10/24/00.
10. “Plenary Session Panel Presentation on Chronic Pelvic Pain Syndrome” AUA Annual
Meeting 2003, Plenary Session Panel Member Chicago, Ill. 4/2003
11. “BPH Surgical Technology Session” AUA Annual Meeting 2003, Podium Session
Moderator. Chicago, Ill. 4/2003
12. New York Section AUA Annual Meeting 2002, Madrid and Barcelona, Spain
1.New Technologies in BPH 10/18/02
2.Heat Therapies in Urology 10/22/02
3.Is Chronic Prostatitis a Male Voiding Dysfunction 10/24/02
4.Photoselective Vaporization of the Prostate (PVP): Initial Experience with the
80 W High Power KTP Laser Vaporization Prostatectomy for the Treatment of
BPH 10/24/02
13. AUA Educational National Postgaduate Course. Update on BPH: Faculty member,
Keystone, Co. 1/8/03-1/12/03
14. New York Section AUA Annual Meeting 2003, Athens Greece
1.Evolution of the Laser Prostatectomy for BPH 10/14/03
2.Combination Medical Therapy for BPH 10/14/03
3.Cooled ThermoTherapy™ / TUMT® for Intractable Chronic Prostatitis – 12
Months after Treatment 10/14/03
4.High power KTP Photoselective Laser Vaporization Prostatectomy for the
Treatment of BPH in Men with Large Prostates J. S. Sandhu, B. A. VanderBrink,
C. Egan, S. A. Kaplan, A. E. Te 10/14/03
15. New York Section AUA Annual Meeting 2004, Venice to Rome, Italy
Scientific Co- Chair and BPH Section Moderator
1.The 80 Watt Quasi Continuous KTP Laser Prostatectomy: The New York
Presbyterian Experience: 10/04
2.Where do new technologies for BPH fit?10/04
3. The USA Experience with the Next Generation High-Energy Microwave
Thermotherapy System (TUMT) for Benign Prostatic Hyperplasia 10/04
16. Second Annual Maurice Gonder, M.D. Urology Symposium at SUNY Stony Brook, NY
-Minimally Invasive Technology in the Management of BPH: A 2005 Perspective
3/19/05
17. National Association for continence Annual Meeting 2005, Durham, NC 11/12/05
-The Male Bladder 11/12/05
-Prostate Health: Tackling BPH with medications and procedures 11/12/05
18. Annual New York Section AUA Meeting 2005, Vienna, Austria
-KTP Laser for Benign Prostatic Enlargement 9/19/05
19. SIU Meeting on Prostatic Diseases 2005, Bariloche, Pantagonia, San Carlos, Argentina
- Lunch Symposium: Innovations in Laser Treatment of BPH: Are All Lasers Created
Equal? 9/30/05
20. AUA Annual Meeting 2005, San Antonio, Texas
- Plenary Session Presenter: BPH Highlights
- Video Session Moderator, Laparoscopic and Robotic Nephroureterectomy, Cystectomy
and Miscellaneous Procedures and Miminally Invasive BPH procedures.
- Discussed Poster Session Moderator, Urologic Infections and Inflammatory Diseases
21. AUA Sponsored Course on BPH ( Co-Director ) Washington, DC. 12/9/05-12/12/05
Lectures given at course
- Debate Panel: The Role of Flow Rates, PVR’s, TRUS, Prostate Biopsies and
Urodynamics
- Introduction to Treatment: What Are We Treating?
- Role of Anticholinergic Therapy with LUTS
- Overview of Invasive Surgical Therapies
22. AUA 2005 Post Graduate Course on BPH, Faculty member
-AUA Webcast Lecture
-Paradigms for Minimally Invasive Therapies for BPH 5/21/05
23. American Society of Laser Medicine and Surgery Annual Meeting 2006, Boston,
Massachusetts
- State of the Art Lecture- Photoselective Vaporization of the Prostate. 4/7/06
- Point Counter Point Session- Greenlight vs. Holmium 4/7/06
24. American Urologic Association Meeting 2006 – CME Symposium
- Emerging trends in prostatectomy and impact of new technologies; advanced techniques
for large glands, difficult or challenging cases and managing patient expectations; tricks
and tips. 5/19/06
25. Hong Kong Urologic Association: State of the Art Symposium on Photoselective
Vaporization of the Prostate.Hong Kong.
-Photoselective Vaporization of the Prostate: Surgical Tips and Caveats. 6/27/2006
26. Michigan Urologic Society Meeting 2006, Ann Arbor, Michigan
-Resident Presentation Judge 5/10/06
-State of the Art Lecture on Photoselective Vaporization of the Prostate 5/10/06
27. The 20th Congress of the Japanese Society of Endourology and ESWL 2006, Osaka, Japan
-State of the Art Point Counterpoint: PVP vs HoLAP 10/6/06
28. Annual New York Section AUA Meeting, Buenos Aires, Argentina
Panelist on Panel Discussion: Male Voiding dysfunction: Best Medical Management on
11/13/07
Lecture: Anticholinergic for LUTS
29. R. Frank Jones Urological Society (RFJUS) of the National Medical Association
(NMA) 2007 Annual Meeting and Scientific Assembly, Honolulu, Hawaii.
-Faculty and Lecturer: Minimally Invasive Treatments for BPH: Which is best? 8/6/07
30. DOD Innovative Minds in Prostate Cancer Today (IMPaCT) meeting, Atlanta, GA
- Poster Presentation: Core per gram ratio predicts prostate cancer detection on transrectal
ultrasound-guided prostate biopsy 09/07/08
31. Annual AUA Post Graduate Course on BPH, San Francisco, Ca
Course Director and Faculty 12/7-8/07
Lecture given at course:
- Bladder Therapies for LUTS
- Office Analgesia
- Novel Minimally Invasive Investigational Therapies for BPH
- Overview of Laser Therapies in BPH
- The High Power 532 nm Laser Techniques
- Laser Hands On
- Thermotherapy Hands On Laboratory
- Heated Battles: Which on to use?
32. 2008 Annual New York Section AUA Meeting, Berlin, Germany
Faculty Panelist on Panel Discussion: Male Voiding dysfunction: Best Medical
Management on 11/13/08
Lecture: 532 nm Lasers in BPH:2008 update
th
33. 26 World Congress of Endourology and SWL Annual Meeting 2008, Shanghai, China.
12/2/08
-BPH: Plenary Faculty Panel Member on Debate
-Thulium vs. Holmium vs 532 nm Laser
34. 2008 ARTP (de l’Association pour la Recherche sur les Tumeurs de la Prostate) Annual
Meeting, Paris, France on 12/5/08 Invited Plenary Faculty Member and Speaker
-Molecular pathways of benign prostatic hyperplasia and my vision of BPH treatment in
the next 10 years
35. AUA 2008 Post Graduate Course on Male Pelvic Health , Faculty member
Bladder Therapies in Men 05/17/2008 Orlando, FL
th
36. 26 World Congress of Endourology & SWL 2008
Faculty Member in Instructional Course 16 on Lasers in BPH on 12/02/08
532 nm Lasers In BPH: 2008 Update
37. AUA 2009 Post Graduate Course on Male Pelvic Health , Faculty member
Technolology Update in Lower Urinary Tract Therapies in Men 05/24/2009 Chicago, Ill
38. AUA 2009 Post Graduate Course on Best Video Awards Course , Chairperson
and Faculty member 05/23/2009 Chicago, Ill
39. AUA 2009 Post Graduate Course on Laser Therapies for BPH: Hands On Course, Faculty
member 05/24/2009 Chicago, Ill
532 nm Lasers for BPH
40. 2009 Annual AUA Post Graduate Course on BPH, New Orleans, La.
Course Director and Faculty 3/6-7/2009
Lecture given at course:
- Bladder Therapies for LUTS
- Office Analgesia
- Overview of Laser Therapies in BPH
- The High Power 532 nm Laser Techniques
- Laser Hands On Laboratory
- Thermotherapy Hands On Laboratory
Date:
Signature:

Curriculum vitae Alexis Edwin Te, M.D. Date of Preparation: April 28, 2010

Transcription

Similar documents